当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件21130条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Degludec
BULK INGREDIENT
0420-9007
Novo Nordisk A/S
20120720
INSULIN DEGLUDEC
BULK INGREDIENT
1
0420-9007_9023b1c1-54e7-4dc9-952d-f6e6400d6150
Semaglutide
BULK INGREDIENT
0420-9008
Novo Nordisk A/S
20171206
SEMAGLUTIDE
BULK INGREDIENT
1
0420-9008_bba1777f-68f6-4333-afea-6309ecc5f14d
Insulin Aspart
BULK INGREDIENT
0420-9010
Novo Nordisk A/S
20100325
INSULIN ASPART
BULK INGREDIENT
1
0420-9010_ad8d29a4-8740-48fe-bcf9-8ae20a18068a
Insulin Detemir
BULK INGREDIENT
0420-9013
Novo Nordisk A/S
20100324
INSULIN DETEMIR
BULK INGREDIENT
1
0420-9013_3f6cf7b4-2aa9-442e-a4e9-1a9f5c0eaddd
semaglutide
DRUG FOR FURTHER PROCESSING
0420-9237
Novo Nordisk A/S
20171206
SEMAGLUTIDE
DRUG FOR FURTHER PROCESSING
.68
0420-9237_edf0742b-b6d1-49ac-81f8-9a98f323b1ae
Semaglutide
DRUG FOR FURTHER PROCESSING
0420-9300
Novo Nordisk A/S
20170602
SEMAGLUTIDE
DRUG FOR FURTHER PROCESSING
.5
0420-9300_f6a5deb3-2347-4680-92d5-ffadb1c93a2d
Semaglutide SNAC
DRUG FOR FURTHER PROCESSING
0420-9520
Novo Nordisk A/S
20190920
SEMAGLUTIDE
DRUG FOR FURTHER PROCESSING
3
0420-9520_d23d9180-43ff-4eb1-880c-500bd3a6ee05
Semaglutide SNAC
DRUG FOR FURTHER PROCESSING
0420-9530
Novo Nordisk A/S
20190920
SEMAGLUTIDE
DRUG FOR FURTHER PROCESSING
7
0420-9530_d23d9180-43ff-4eb1-880c-500bd3a6ee05
Semaglutide SNAC
DRUG FOR FURTHER PROCESSING
0420-9540
Novo Nordisk A/S
20190920
SEMAGLUTIDE
DRUG FOR FURTHER PROCESSING
14
0420-9540_d23d9180-43ff-4eb1-880c-500bd3a6ee05
Risedronate Sodium
DRUG FOR FURTHER PROCESSING
0430-0473
Allergan, Inc.
20020517
RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE
DRUG FOR FURTHER PROCESSING
30.1; 4.9
0430-0473_ed79aa09-27c9-4f72-8083-5b80630aca29
Risedronate Sodium
DRUG FOR FURTHER PROCESSING
0430-0487
Allergan, Inc.
20080422
RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE
DRUG FOR FURTHER PROCESSING
129; 21
0430-0487_ed79aa09-27c9-4f72-8083-5b80630aca29
risedronate sodium
DRUG FOR FURTHER PROCESSING
0430-0970
Allergan, Inc.
20101201
RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE
DRUG FOR FURTHER PROCESSING
30.1; 4.9
0430-0970_98d71141-4186-4c5c-ab70-838e733062e9
Palmitic Acid
DRUG FOR FURTHER PROCESSING
0441-0670
Sigma-Aldrich Corporation
19860220
PALMITIC ACID
DRUG FOR FURTHER PROCESSING
1
0441-0670_2df93cfc-8ee8-5c05-e063-6294a90a0501
Colfosceril Palmitate
BULK INGREDIENT
0441-0726
Sigma-Aldrich Corporation
19980901
COLFOSCERIL PALMITATE
BULK INGREDIENT
1
0441-0726_26b7fac0-5140-6ce9-e063-6394a90ab080
Colfosceril Palmitate
BULK INGREDIENT
0441-0726
Sigma-Aldrich Corporation
19980901
COLFOSCERIL PALMITATE
BULK INGREDIENT
1
0441-0726_5d04fd77-8646-587a-e053-2a91aa0a5a25
Tripalmitin
BULK INGREDIENT
0441-0904
Sigma-Aldrich Corporation
19851223
TRIPALMITIN
BULK INGREDIENT
1
0441-0904_31f6cbea-7b37-db9d-e063-6294a90ad268
Ferumoxytol Drug Substance
BULK INGREDIENT
0441-1521
Sigma-Aldrich Corporation
20101019
FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE
BULK INGREDIENT
200
0441-1521_26b810e6-adc8-6e54-e063-6394a90ae943
Inosine
BULK INGREDIENT
0441-2770
Sigma-Aldrich Corporation
20140924
INOSINE
BULK INGREDIENT
3
0441-2770_2654805e-fe86-df93-e063-6394a90a0396
Glatiramer Acetate
BULK INGREDIENT
0441-3642
Sigma-Aldrich Corporation
20150416
GLATIRAMER ACETATE
BULK INGREDIENT
1
0441-3642_2f136656-9093-5934-e063-6294a90a80c2
vilazodone hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1111
Allergan, Inc.
20110429
VILAZODONE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
10
0456-1111_760691a3-e2c6-46fb-b596-ab19b331ec4d
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3